Avidity Biosciences
RNA
#1870
Rank
C$15.13 B
Marketcap
C$100.43
Share price
-0.01%
Change (1 day)
145.23%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$15.13 Billion

As of January 2026 Avidity Biosciences has a market cap of C$15.13 Billion. This makes Avidity Biosciences the world's 1870th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026C$15.13 B1.67%
2025C$14.88 B188.72%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Avidity Biosciences was reported to be:

C$15.13 Billion
by Nasdaq info icon info icon
C$15.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
C$8.77 B-42.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.13 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.13 B-79.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$3.81 B-74.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.16 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.17 B 0.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$198.14 B 1,209.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$139.62 B 822.67%๐Ÿ‡ฌ๐Ÿ‡ง UK